Navigation Links
Neurocrine Biosciences Announces the Start of Second Phase III Study of Elagolix in Endometriosis
Date:8/29/2013

p>Elagolix inhibits gonadotropin releasing hormone (GnRH) receptors in the pituitary gland and ultimately reduces circulating sex hormone levels. To date, elagolix has been studied in over 20 clinical trials totaling more than 1,000 subjects. At the time of expected NDA filing for endometriosis, elagolix will have been studied in over 25 clinical trials and in excess of 3,000 subjects. A Phase IIb trial of elagolix for the treatment of uterine fibroids is also ongoing.

About Neurocrine Biosciences

Neurocrine Biosciences, Inc. is a clinical stage drug discovery company primarily focused on neurological and endocrine based diseases and disorders. The Company discovers and develops innovative pharmaceuticals, in diseases with high unmet medical needs or where the existing drug classes are inadequate, through a disciplined yet entrepreneurial process. Utilizing a portfolio approach to drug discovery, Neurocrine has multiple small molecule drug candidates at various stages of pharmaceutical development. Neurocrine's two lead late stage clinical programs are elagolix, a GnRH antagonist for women's health that is partnered with AbbVie Inc., and a wholly owned VMAT2 inhibitor for the treatment of movement disorders. Neurocrine Biosciences, Inc. news releases are available through the Company's website via the internet at http://www.neurocrine.com.

In addition to historical facts, this press release may contain forward-looking statements that involve a number of risks and uncertainties. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with Neurocrine's business and finances in general, as well as risks and uncertainties associated with the Company's GnRH program and Company overall. Specifically, the risks and uncertainties the Company faces with respect to the Company's GnRH program include,
'/>"/>

SOURCE Neurocrine Biosciences, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Neurocrine Biosciences to Present at the Jefferies 2013 Global Healthcare Conference
2. Neurocrine Biosciences to Present At The Deutsche Bank 38th Annual dbAccess Health Care Conference
3. Neurocrine Biosciences Reports First Quarter 2013 Results
4. Neurocrine Biosciences to Present at the Needham 12th Annual Healthcare Conference
5. Neurocrine Biosciences Announces the Start of Phase IIb Study of Elagolix in Uterine Fibroids
6. Neurocrine Biosciences To Present At The 25th Annual Roth Conference
7. Neurocrine Biosciences To Present At The Cowen And Company 33rd Annual Health Care Conference
8. Neurocrine Biosciences To Present At The Leerink Swann Global Healthcare Conference 2013
9. Neurocrine Biosciences Announces Conference Call And Webcast To Present Fourth Quarter And Year-End 2012 Financial Results
10. Neurocrine Biosciences Announces Additional European And United States Patents Issued On Proprietary VMAT2 Inhibitor
11. Neurocrine Biosciences To Present At Deutsche Banks 2012 dbAccess BioFEST
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2014)... , Nov. 21, 2014  CytoSorbents Corporation (OTCQB: ... European Union approved CytoSorb® cytokine adsorber to treat ... the Beacon of Light Award at last night,s ... Dr. Phillip Chan , Chief ... honor to be recognized by the New Jersey ...
(Date:11/22/2014)... Statistics released from a number of organizations ... during the holidays, beginning with Thanksgiving eve, which is ... The data, highlighted in an Infographic ... of their annual Sober Days for the Holidays ... drinking and increased rates of DUI injuries and deaths ...
(Date:11/22/2014)... Nov. 21, 2014 Research and Markets  has ... Drug Industry Report, 2014-2017" report to their offering. ... The Chinese recombinant protein drug market has been expanding ... ability and the like. During 2005-2013, sales of recombinant ... a CAGR of 19.1%, and it is projected that ...
Breaking Medicine Technology:CytoSorbents Wins Beacon of Light Award 2CytoSorbents Wins Beacon of Light Award 3CytoSorbents Wins Beacon of Light Award 4Alarming Stats Show Holiday Drinking an Issue for Many 2China Recombinant Protein Drug Industry Report, 2014-2017 2China Recombinant Protein Drug Industry Report, 2014-2017 3
... HASCO Medical, Inc. (OTC Bulletin Board: HASC ... serves patients in Alabama, Florida, and Mississippi, today announced ... subsidiary of HASCO Medical, has signed an agreement with ... of the agreement, SMM will be providing high-end rehabilitation chairs ...
... NEW YORK, Jan. 13, 2011 Reportlinker.com announces ... in its catalogue: Merck & ... http://www.reportlinker.com/p074950/Merck--Co-Inc-PharmaVitae-Profile.html IntroductionThis analysis examines ... Co. in the prescription pharmaceutical sector. The profile ...
Cached Medicine Technology:HASCO Medical Signs Agreement With the State of Alabama 2Reportlinker Adds Merck & Co., Inc.: PharmaVitae Profile 2
(Date:11/24/2014)... 2014 The Healthy Skin Care Journal, ... affordable skin care products, recently announced its launch. Located ... a wide variety of articles, tips, and evaluations about ... skincare alternatives. , According to Emily Lataille, the website’s ... includes thoroughly researched reviews, tips for the skin, and ...
(Date:11/24/2014)... Alexandria, VA (PRWEB) November 24, 2014 ... will hold its 12th annual International Symposium on Malignant ... in Bethesda, Maryland. Daytime conference sessions will take place ... in Bethesda, while dinners, including a community dinner and ... Regency Bethesda. , Sessions will cover a range of ...
(Date:11/24/2014)... November 24, 2014 Abington Health ... MD has joined The Neurology Group and has ... Sclerosis Center. , A graduate of Vinnica Medical ... at Albert Einstein Medical Center in Philadelphia and completed ... Multiple Sclerosis Center at Weill Cornell Medical College. Ternopolska ...
(Date:11/24/2014)... A new sports massage technique available ... and massage therapy provider, announced it newest massage ... newest sports massage is a fast-acting, “to-the-point” ... sports massage and ESM is that ESM has ... "reset button,” and ESM can increase flexibility, elasticity, ...
(Date:11/24/2014)... November 24, 2014 Recently, SweetDressy.com, a ... unveiled its new collection of 2014 Evening Dresses. All ... According to the company’s marketing manager, the special offer ... for more. , Sweetdressy.com has been working well ... to unveil the latest designs. Their new dresses may ...
Breaking Medicine News(10 mins):Health News:Skin Care Advice Blog The Healthy Skin Care Journal Now Accessible to the Public 2Health News:2015 International Symposium on Malignant Mesothelioma Will Take Place at the National Institutes of Health Campus 2Health News:2015 International Symposium on Malignant Mesothelioma Will Take Place at the National Institutes of Health Campus 3Health News:Nataliya Ternopolska Named Associate Medical Director of Abington Health’s Multiple Sclerosis Center 2Health News:Sports Massage in London by Massaggi Presents New Technique to Reset Muscles, Rapidly Eliminate Pain 2Health News:Sports Massage in London by Massaggi Presents New Technique to Reset Muscles, Rapidly Eliminate Pain 3Health News:SweetDressy.com Unveiled A New Selection Of Evening Dresses 2
... able to delay the onset of the disease or even ... to a study presented today at the annual meeting of ... the results of our study, participating in a high-impact activity, ... least three times a week appears associated with more degenerated ...
... CHICAGO Women with a personal history of breast ... to mammography, according to a study presented today at ... America (RSNA). The American Cancer Society (ACS) guidelines ... with a known gene mutation or with a strong ...
... Institute of Neurological Disease (GIND) in San Francisco have ... a mouse model of Alzheimer,s disease (AD). Humans with ... have abnormally low levels of an enzyme called EphB2 ... in such mice by gene therapy completely fixed their ...
... , SUNDAY, Nov. 28 (HealthDay News) -- The contents of ... nutrition, a new study shows. U.S. researchers examined the ... of 5,930 students at 152 schools. The vending machines in ... value, including chips, sodas and sweets. In elementary schools ...
... , FRIDAY, Nov. 26 (HealthDay News) -- There are a ... Friday," says a University of Delaware researcher. Black Friday, ... holiday shopping season. "If people put a lot of ... who were likely to be the misbehavers on Black Friday," ...
... FRIDAY, Nov. 26 (HealthDay News) -- If you,re told that ... reaction and carefully consider the situation, advises an expert. ... temptation to respond defensively with ,not my child., Understand that ... professor of health services at Saint Joseph,s University in Philadelphia, ...
Cached Medicine News:Health News:Light exercise may prevent osteoarthritis 2Health News:Women with personal history of breast cancer should be screened with MRI 2Health News:Gene therapy prevents memory problems in mice with Alzheimer's disease 2Health News:Parents of Bullies Urged to Open Lines of Communication 2
Inquire...
... CLOtest Rapid Urease Test is recognized by ... urease tests because of its accuracy, convenience ... Marshall, MD. who, along with Robin Warren, ... correlation between H. pylori and gastric ulcers. ...
Serim PyloriTek Test Kit detects urease activity in gastric biopsy specimens for the presumptive identification of an Helicobacter pylori infection....
... The QuickVue H.pylori gII test is a ... qualitative detection of IgG antibodies specific to ... whole blood. It utilizes a convenient, non-invasive, ... aid physicians in the diagnosis of H.pylori ...
Medicine Products: